{
"NDC": {
"NDCCode": "69784-130-01",
"PackageDescription": "473 mL in 1 BOTTLE (69784-130-01) ",
"NDC11Code": "69784-0130-01",
"ProductNDC": "69784-130",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Pyridostigmine Bromide",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Pyridostigmine Bromide",
"DosageFormName": "SOLUTION",
"RouteName": "ORAL",
"StartMarketingDate": "20221215",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA212405",
"LabelerName": "Woodward Pharma Services LLC",
"SubstanceName": "PYRIDOSTIGMINE BROMIDE",
"StrengthNumber": "60",
"StrengthUnit": "mg/5mL",
"Pharm_Classes": "Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]",
"DEASchedule": null,
"Status": "Deprecated",
"LastUpdate": "2024-10-19",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20251231",
"StartMarketingDatePackage": "20221215",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}